Want to see GB:RKT full AI Analyst Report?
Top Page
Reckitt
(LSE:RKT)
Select Model
Select Model
Rating:72Outperform
Price Target:
5,745.00 p
▲(11.38% Upside)
Action:Upgraded
Date:07/29/26
Overall score reflects stronger financial quality (notably higher profitability and improved leverage) and a supportive valuation (low-to-moderate P/E with a high dividend yield). These positives are tempered by mixed technical positioning (below the 200-day average) and execution/cash-flow risks highlighted on the earnings call, including weak H1 cash conversion and ongoing cost/supply headwinds despite reiterated guidance.
Positive Factors
Emerging-market growth
Sustained emerging-market growth, particularly in China and India, expands Reckitt’s addressable consumer base and supports durable volume and brand adoption. Repeated double-digit performance suggests stronger regional market positions rather than a single-quarter uplift.
Negative Factors
Infant-formula litigation risk
The Mead Johnson Enfamil litigation creates a potentially material, multi-year liability and reputational risk in infant nutrition. The ongoing bellwether trial and large consolidated caseload could pressure cash generation, management attention and the economics of the category.
Read all positive and negative factors
Positive Factors
Negative Factors
Emerging-market growth
Sustained emerging-market growth, particularly in China and India, expands Reckitt’s addressable consumer base and supports durable volume and brand adoption. Repeated double-digit performance suggests stronger regional market positions rather than a single-quarter uplift.
Read all positive factors
Reckitt (RKT) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£32.01B
Dividend Yield6.68%
Average Volume (3M)1.59M
Price to Earnings (P/E)11.2
Beta (1Y)0.96
Revenue Growth-2.49%
EPS Growth133.91%
CountryUK
Employees36,200
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)4.46
Shares Outstanding634,428,700
10 Day Avg. Volume1,273,878
30 Day Avg. Volume1,594,136
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)5.26
Price to Sales (P/S)2.87
P/FCF Ratio23.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£6,228.00Price Target Upside20.74% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)3.37
Revenue Forecast (FY)£13.11B
Reckitt Business Overview & Revenue Model
Company Description
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsi...
How the Company Makes Money
Reckitt makes money primarily by selling branded consumer products to large retailers, wholesalers/distributors, pharmacies, and e-commerce platforms, generating revenue from the wholesale price (net of discounts, returns, and trade promotions) on...
Reckitt Earnings Call Summary
Earnings Call Date:Jul 29, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Mar 03, 2027
Earnings Call Sentiment Positive
The call presented clear evidence of operational recovery and momentum: strong Q2 acceleration, notable outperformance in emerging markets (especially China), successful innovation rollouts, improved-than-expected margin performance versus prior guidance, and continued disciplined capital returns and cost transformation under the Fuel for Growth program. Offsetting these positives were persistent input cost and commodity pressures, regional supply disruptions (Middle East), category challenges in Household Care/Auto Dish and a near-term EPS and free cash flow hit from the Essential Home divestment. Management reiterated full-year guidance and laid out specific mitigation actions, suggesting confidence in execution. Overall, the positive developments (broad-based revenue acceleration, emerging markets strength, innovation wins, and cost program progress) materially outweigh the nearer-term lowlights and structural headwinds.Positive Updates
Quarterly Acceleration in Revenue Growth
Group like-for-like net revenue grew 2.6% in H1 2026 with strong acceleration in Q2: Core Reckitt like-for-like net revenue +2.7% H1 and +4.2% in Q2; Group Q2 growth of 4.7% (Core Reckitt and Mead Johnson combined). Growth was balanced between volume and price/mix.
Negative Updates
Adjusted EPS Decline
Adjusted EPS declined 9.7% to 152.1p in H1 2026, principally driven by the divestment of Essential Home and lower operating profit from higher input costs.
Read all updates
Q2-2026 Updates
Positive
Negative
Quarterly Acceleration in Revenue Growth
Group like-for-like net revenue grew 2.6% in H1 2026 with strong acceleration in Q2: Core Reckitt like-for-like net revenue +2.7% H1 and +4.2% in Q2; Group Q2 growth of 4.7% (Core Reckitt and Mead Johnson combined). Growth was balanced between volume and price/mix.
Read all positive updates
Company Guidance
Reckitt reiterated unchanged full‑year guidance for Core Reckitt of 4–5% like‑for‑like net revenue growth and reiterated adjusted operating profit margin guidance for Core Reckitt and Mead Johnson of 24.9–25.6% for 2026 (with a significantly stronger second half), while expecting emerging markets to deliver H2 growth similar to H1 (emerging markets H1 +8.5% and Q2 +9.4%, or +10.3% excl. Russia Hygiene); Europe is expected to return to like‑for‑like growth in H2 with sequential improvement, North America to be stronger in H2 and weighted to Q4, and seasonal OTC incidence is planned slightly higher than the prior season. Management confirmed Fuel for Growth remains on track (total program cost ~£1.0bn, ~£350m in 2026) with fixed costs at 20.1% of net revenue in H1 and a target of below 19% by end‑2027, announced a new £500m 12‑month share buyback and a 5% interim dividend increase, and flagged H1 metrics including adjusted EPS 152.1p (‑9.7% y/y), free cash flow £419m (cash conversion 42%), net debt/EBITDA 2.5x and cumulative shareholder returns of ~£6.4bn since the strategy launch.Reckitt Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.63B | 14.21B | 14.17B | 14.61B | 14.45B | 13.23B |
| Gross Profit | 8.11B | 8.49B | 8.60B | 8.76B | 8.36B | 7.69B |
| EBITDA | 4.80B | 3.92B | 2.95B | 3.19B | 3.90B | 465.00M |
| Net Income | 2.88B | 3.18B | 1.43B | 1.64B | 2.33B | -32.00M |
Balance Sheet | ||||||
| Total Assets | 24.43B | 25.07B | 25.30B | 27.14B | 28.74B | 26.95B |
| Cash, Cash Equivalents and Short-Term Investments | 878.00M | 1.95B | 760.00M | 1.39B | 1.16B | 1.26B |
| Total Debt | 10.16B | 8.43B | 8.66B | 8.54B | 8.88B | 9.56B |
| Total Liabilities | 18.72B | 17.29B | 18.58B | 18.67B | 19.26B | 19.49B |
| Stockholders Equity | 5.67B | 7.75B | 6.70B | 8.45B | 9.44B | 7.40B |
Cash Flow | ||||||
| Free Cash Flow | 1.55B | 1.76B | 2.22B | 2.19B | 1.95B | 1.32B |
| Operating Cash Flow | 2.10B | 2.30B | 2.68B | 2.64B | 2.40B | 1.70B |
| Investing Cash Flow | 1.14B | 1.20B | -396.00M | -466.00M | -139.00M | 239.00M |
| Financing Cash Flow | -3.22B | -2.43B | -2.71B | -1.81B | -2.38B | -2.29B |
Reckitt Technical Analysis
Negative
5158.00
Price Trends
5076.59
Negative
4835.80
Positive
5234.55
Negative
Market Momentum
1.36
Positive
43.12
Neutral
6.61
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:RKT, the sentiment is Negative. The current price of 5158 is above the 20-day moving average (MA) of 5109.05, above the 50-day MA of 5076.59, and below the 200-day MA of 5234.55, indicating a bearish trend. The MACD of 1.36 indicates Positive momentum. The RSI at 43.12 is Neutral, neither overbought nor oversold. The STOCH value of 6.61 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:RKT.
Reckitt Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £16.73B | 18.80 | 25.10% | 2.30% | 12.76% | 12.70% | |
73 Outperform | £87.84B | 13.80 | 13.38% | 6.02% | 0.70% | 110.32% | |
72 Outperform | £32.01B | 11.18 | 42.87% | 6.68% | -2.49% | 133.91% | |
71 Outperform | £14.25B | 15.07 | 8.44% | 3.12% | -2.16% | -24.87% | |
68 Neutral | £101.16B | 20.94 | 37.05% | 3.57% | -20.44% | 4.96% | |
66 Neutral | £18.72B | 11.47 | 39.24% | 6.69% | 4.73% | -28.94% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
* Consumer Defensive Sector Average
GB:RKT
Reckitt
5,058.00
-473.44
-8.56%
GB:ABF
Associated British Foods
1,860.00
-15.62
-0.83%
GB:BATS
British American Tobacco
4,092.00
126.14
3.18%
GB:CCH
Coca Cola HBC
4,496.00
872.53
24.08%
GB:IMB
Imperial Brands
2,488.00
-524.69
-17.42%
GB:ULVR
Unilever
4,559.00
-239.16
-4.98%
Reckitt Corporate Events
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Tightens Capital Base With New Share Buyback
Positive
Aug 17, 2026
Reckitt Benckiser Group plc has repurchased a series of its own ordinary shares between 10 August and 14 August 2026, acquiring tranches of around 28,000 to 31,000 shares per day via Citigroup Global Markets. The shares, bought under an existing s...
Business Operations and StrategyPrivate Placements and Financing
Reckitt’s Mead Johnson Unit Cuts 2044 Debt and Drops Parent Guarantee
Positive
Aug 14, 2026
Reckitt’s subsidiary Mead Johnson Nutrition Company has completed an any-and-all cash tender offer for its 4.600% Senior Notes due 2044, setting total consideration at $898 per $1,000 of principal plus accrued interest. The offer resulted in...
Stock BuybackRegulatory Filings and Compliance
Reckitt Increases Treasury Stock After August Share Buyback
Neutral
Aug 10, 2026
Reckitt Benckiser Group plc has repurchased 84,700 ordinary shares between 5 and 7 August 2026 through Citigroup Global Markets, under authority granted at its May 2026 AGM, and will hold the repurchased stock in treasury. Following these transact...
Business Operations and StrategyPrivate Placements and Financing
Reckitt’s Mead Johnson Launches Tender Offer for 2044 Notes and Seeks Indenture Changes
Neutral
Aug 5, 2026
Reckitt’s wholly owned subsidiary Mead Johnson Nutrition Company has launched an any-and-all cash tender offer for its $500 million 4.600% senior notes due 2044, coupled with a consent solicitation to amend the governing indenture.The propos...
Business Operations and StrategyStock Buyback
Reckitt launches £500m share buyback to boost shareholder returns
Positive
Aug 4, 2026
Reckitt Benckiser Group plc has launched a new share buyback programme of up to £500 million over the next 12 months, aimed at increasing returns to shareholders and reducing the company’s share capital. The programme begins with a firs...
Regulatory Filings and Compliance
Reckitt updates share capital and total voting rights
Neutral
Aug 3, 2026
Reckitt Benckiser has reported that, as of 31 July 2026, it has 674,005,752 issued ordinary shares, of which 38,922,325 are held in treasury and carry no voting rights. This leaves a total of 635,083,427 voting shares in issue, a figure that share...
Stock BuybackDividendsFinancial DisclosuresRegulatory Filings and Compliance
Reckitt lifts interim dividend and unveils £500m share buyback
Positive
Jul 29, 2026
Reckitt has published its half‑year results for the six months to 30 June 2026, making the full statement available on its website and via the U.K. regulator’s national storage mechanism. The company is coupling the release with an inv...
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Reckitt to Exit Russian Hygiene Business with Sale to Arnest
Negative
Jul 24, 2026
Reckitt has agreed to sell its Russian Hygiene business to Arnest Management, a Russian manufacturer of consumer goods and packaging, with completion targeted for the second half of 2026 subject to UK regulatory approvals. The unit accounted for a...
Business Operations and StrategyRegulatory Filings and Compliance
Reckitt Updates Share Capital and Voting Rights Totals
Neutral
Jul 1, 2026
Reckitt Benckiser Group plc has confirmed that, as of 30 June 2026, it has 674,005,752 issued ordinary shares, of which 38,950,759 are held in treasury with suspended voting rights, resulting in 635,054,993 total voting rights. The updated voting ...
Business Operations and StrategyRegulatory Filings and Compliance
Reckitt directors buy shares, signaling confidence in consumer goods group
Positive
Jun 25, 2026
Reckitt Benckiser has disclosed that three non-executive directors, Deepak Nath, Harry Kirsch and Pat Verduin, purchased ordinary shares in the company on 23 June 2026 on the London Stock Exchange and Aquis Exchange. The relatively modest but conc...
DividendsRegulatory Filings and Compliance
Reckitt CEO and CFO Reinvest Dividends Into Company Shares
Positive
Jun 16, 2026
Reckitt Benckiser Group has disclosed that chief executive officer Kris Licht acquired 2,047 ordinary shares via the company’s Dividend Reinvestment Plan at £46.33799 per share on 12 June, in a transaction executed on the London Stock E...
Business Operations and StrategyExecutive/Board Changes
Reckitt Adds Healthcare and Tech Heavyweights to Board
Positive
Jun 16, 2026
Reckitt has strengthened its board by appointing ViiV Healthcare chief executive and GSK executive committee member Deborah Waterhouse, and former BT Group chief executive and ex-Salesforce president Gavin Patterson, as non-executive directors eff...
Business Operations and StrategyStock Buyback
Reckitt Completes £1 Billion Share Buyback Programme
Positive
Jun 16, 2026
Reckitt Benckiser Group plc, the consumer health and hygiene products company behind brands such as Dettol, Durex and Lysol, focuses on science-based solutions that support everyday health and hygiene. The group also underlines a broader mission t...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Buys Back Shares, Updates Voting Rights Total
Positive
Jun 16, 2026
Reckitt Benckiser Group has repurchased 74,260 of its ordinary shares on 15 June 2026 from Deutsche Bank’s London branch, under a previously approved buyback authority, and will hold the acquired stock in treasury. Following this transaction...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Tightens Share Base With Further Treasury Buyback
Positive
Jun 15, 2026
Reckitt Benckiser Group plc has repurchased 194,000 ordinary shares from Deutsche Bank’s London branch under its existing shareholder authority, with the shares to be held in treasury. Following this transaction, Reckitt holds 38,882,655 sha...
Stock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Adds to Treasury Stock with Latest Share Buyback
Positive
Jun 12, 2026
Reckitt Benckiser has repurchased 194,500 of its ordinary shares on 11 June 2026, at a volume-weighted average price of 4,615.90 pence per share, under the share buyback authority granted by shareholders earlier this year. The company will hold th...
Business Operations and StrategyStock Buyback
Reckitt Benckiser Adds to Treasury Stock in Ongoing Share Buyback
Positive
Jun 11, 2026
Reckitt Benckiser Group has repurchased 206,919 of its ordinary shares on 10 June 2026 from Deutsche Bank AG, London Branch under an existing shareholder-authorised buyback programme. The repurchased shares will be held in treasury, reflecting ong...
Stock Buyback
Reckitt Expands Treasury Stock with Fresh Share Buyback
Positive
Jun 10, 2026
Reckitt Benckiser Group has continued its share buyback activity, purchasing 205,000 ordinary shares on 9 June 2026 from Deutsche Bank’s London branch under authority granted by shareholders earlier this year. The shares, bought at a volume-...
Private Placements and FinancingRegulatory Filings and Compliance
Reckitt Adds €150m to 4% 2035 Note Series Under EMTN Programme
Positive
Jun 8, 2026
Reckitt has priced a new EUR 150 million tranche of 4.0% notes due 28 May 2035 under its EUR 10 billion Euro Medium Term Note Programme, to be issued by Reckitt Benckiser Treasury Services and guaranteed by the parent company. The new notes will b...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Updates Share Capital After Treasury Share Buyback
Positive
Jun 8, 2026
Reckitt Benckiser Group plc has repurchased 142,219 of its ordinary shares on 5 June 2026, at a volume-weighted average price of 4,519.99 pence per share, with the shares to be held in treasury. Following this transaction, Reckitt now holds 37,880...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Adds to Treasury Stock with New Share Buyback
Positive
Jun 5, 2026
Reckitt Benckiser has repurchased 211,000 of its ordinary shares on 4 June 2026 from Deutsche Bank’s London branch under an existing shareholder authority, paying a volume-weighted average price of 4,490.68 pence per share. The acquired shar...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Updates Share Count After Latest Treasury Share Buyback
Positive
Jun 4, 2026
Reckitt Benckiser Group has repurchased 212,000 ordinary shares on 3 June 2026 from Deutsche Bank’s London branch under its existing shareholder authority, with the shares to be held in treasury. Following this transaction, the company holds...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Updates Capital Structure After June Share Buyback
Positive
Jun 3, 2026
Reckitt Benckiser Group plc has repurchased 211,500 of its ordinary shares on 2 June 2026 from Deutsche Bank AG’s London branch under an existing shareholder authority, with the shares to be held in treasury. Following this transaction, Reck...
Regulatory Filings and Compliance
Reckitt chair and non-executive director lift holdings with LSE share purchases
Positive
Jun 2, 2026
Reckitt Benckiser Group has disclosed share purchases by its chair, Jeremy Darroch, and non-executive director Tamara Ingram under U.K. market abuse and transparency rules. Darroch bought 2,132 ordinary shares at £46.87 each, while Ingram acq...
Business Operations and StrategyStock BuybackFinancial Disclosures
Reckitt Buys Back 209,547 Shares, Updates Voting Rights Count
Positive
Jun 2, 2026
Reckitt Benckiser Group plc has executed a share repurchase, buying 209,547 ordinary shares from Deutsche Bank AG, London Branch, to be held in treasury under authority granted by shareholders earlier this year. The shares were acquired at prices ...
Other
Reckitt Non-Executive Directors Boost Holdings with Fresh Share Purchases
Positive
Jun 1, 2026
Reckitt disclosed that several non-executive directors, including Andrew Bonfield, Marybeth Hays, Elane Stock, Fiona Dawson and Stefan Oschmann, have purchased ordinary shares in the company on the London Stock Exchange. The transactions, executed...
Regulatory Filings and Compliance
Reckitt Updates Total Voting Rights After Treasury Share Holdings
Neutral
Jun 1, 2026
Reckitt Benckiser Group plc reported that, as of 31 May 2026, it has 674,005,752 issued ordinary shares, of which 36,516,209 are held in treasury with suspended voting rights. This leaves a total of 637,489,543 voting shares in issue, a figure tha...
Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 192,000 Shares, Updates Voting Rights Count
Neutral
Jun 1, 2026
Reckitt Benckiser Group has repurchased 192,000 ordinary shares on 29 May 2026 from Deutsche Bank’s London branch under its previously authorised buyback programme, paying a volume-weighted average price of 4,660.56 pence per share and retai...
Stock BuybackRegulatory Filings and Compliance
Reckitt Tightens Free Float With Latest Treasury Share Buyback
Neutral
May 29, 2026
Reckitt Benckiser Group has repurchased 189,631 ordinary shares on 28 May 2026 from Deutsche Bank’s London branch under its existing shareholder authority, with the shares to be held in treasury. Following this transaction, Reckitt now holds...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Updates Voting Rights After Treasury Share Buyback
Positive
May 28, 2026
Reckitt Benckiser Group plc has repurchased 29,043 of its ordinary shares on 27 May 2026 from Deutsche Bank AG’s London branch under an existing shareholder authority, with the shares to be held in treasury. Following this transaction, Recki...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 190,000 Shares, Updates Voting Rights Count
Positive
May 27, 2026
Reckitt Benckiser has repurchased 190,000 of its ordinary shares on 26 May 2026 from Deutsche Bank’s London branch under a previously authorised buyback mandate, paying a volume-weighted average price of 4,699.06 pence per share. The shares,...
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Reckitt raises €1.15bn in euro notes to extend funding profile
Positive
May 26, 2026
Reckitt Benckiser Group has tapped the debt markets via its treasury arm, launching and pricing two euro-denominated tranches under its €10 billion Euro Medium Term Note programme. The company placed €650 million of 3.5% notes maturing...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt boosts treasury stock with latest share buyback
Positive
May 26, 2026
Reckitt Benckiser Group has executed a further share buyback, repurchasing 189,000 ordinary shares on 22 May 2026 through Deutsche Bank and placing them into treasury. The move, conducted under an existing shareholder-authorised programme, increas...
Business Operations and StrategyStock Buyback
Reckitt Buys Back 190,000 Shares, Updates Voting Rights Total
Positive
May 22, 2026
Reckitt Benckiser Group has repurchased 190,000 ordinary shares on 21 May 2026 from Deutsche Bank AG’s London branch under its existing shareholder authority, paying a volume-weighted average price of 4,703.35 pence per share. The shares wil...
Business Operations and StrategyExecutive/Board ChangesStock BuybackDividendsFinancial DisclosuresShareholder Meetings
Reckitt Wins Strong Shareholder Backing at 2026 AGM, Approves Dividend and Board Mandates
Positive
May 21, 2026
Reckitt shareholders overwhelmingly backed all resolutions at the 21 May 2026 AGM, including approval of the 2025 Annual Report, the directors’ remuneration report and a final dividend of 127.8 pence per share. The result signals broad inves...
Stock BuybackRegulatory Filings and Compliance
Reckitt Boosts Treasury Stock with 192,000-Share Buyback
Neutral
May 21, 2026
Reckitt Benckiser Group PLC has repurchased 192,000 of its ordinary shares on 20 May 2026 from Deutsche Bank AG’s London branch under its shareholder-approved buyback authority. The shares, bought at a volume-weighted average price of 4,677....
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt boosts treasury stock with latest share repurchase
Positive
May 20, 2026
Reckitt Benckiser Group has repurchased 165,018 ordinary shares on 19 May 2026 under its shareholder-authorised buyback programme, at a volume-weighted average price of 4,724.88 pence per share. The shares will be held in treasury, indicating cont...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Adds to Treasury Stock in Latest Share Buyback
Positive
May 19, 2026
Reckitt Benckiser has repurchased 114,461 of its ordinary shares on 18 May 2026 from Deutsche Bank AG’s London branch under an existing shareholder authority, with the shares to be held in treasury. Following this transaction, the company no...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Expands Treasury Stock with Latest Share Buyback
Positive
May 18, 2026
Reckitt Benckiser has repurchased 205,000 of its ordinary shares on 15 May 2026 from Deutsche Bank AG’s London branch under an existing shareholder-authorised buyback programme, with the shares to be held in treasury. Following this transact...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.